Cargando…

Induction of GD3/α1-adrenergic receptor/transglutaminase 2-mediated erythroid differentiation in chronic myelogenous leukemic K562 cells

The disialic acid-containing glycosphingolipid GD3 recruited membrane transglutaminase 2 (TG2) as a signaling molecule for erythroid differentiation in human chronic myelogenous leukemia (CML) K562 cells. The α1-adrenergic receptor (α1-AR)/TG2-mediated signaling pathway regulated GD3 functions, incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Sun-Hyung, Kang, Sung-Koo, Choi, Hyunju, Kwak, Choong-Hwan, Abekura, Fukushi, Park, Jun-Young, Kwon, Kyung-Min, Chang, Hyeun-Wook, Lee, Young-Choon, Ha, Ki-Tae, Hou, Bo Kyeng, Chung, Tae-Wook, Kim, Cheorl-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641123/ https://www.ncbi.nlm.nih.gov/pubmed/29069780 http://dx.doi.org/10.18632/oncotarget.20080

Ejemplares similares

Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells
por: Ha, Sun-Hyung, et al.
Publicado: (2017)

Induction of Apoptosis and Antitumor Activity of Eel Skin Mucus, Containing Lactose-Binding Molecules, on Human Leukemic K562 Cells
por: Kwak, Choong-Hwan, et al.
Publicado: (2015)

Exogenous and Endogeneous Disialosyl Ganglioside GD1b Induces Apoptosis of MCF-7 Human Breast Cancer Cells
por: Ha, Sun-Hyung, et al.
Publicado: (2016)

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

Inhibition of abl Oncogene Tyrosine Kinase Induces Erythroid Differentiation of Human Myelogenous Leukemia K562 Cells
por: Honma, Yoshio, et al.
Publicado: (1990)

Transcriptional Activation of Human GD3 Synthase (hST8Sia I) Gene in Curcumin-Induced Autophagy in A549 Human Lung Carcinoma Cells
por: Lee, Miri, et al.
Publicado: (2018)

4-O-Carboxymethylascochlorin Inhibits Expression Levels of on Inflammation-Related Cytokines and Matrix Metalloproteinase-9 Through NF–κB/MAPK/TLR4 Signaling Pathway in LPS-Activated RAW264.7 Cells
por: Park, Junyoung, et al.
Publicado: (2019)

Ascofuranone inhibits lipopolysaccharide–induced inflammatory response via NF-kappaB and AP-1, p-ERK, TNF-α, IL-6 and IL-1β in RAW 264.7 macrophages
por: Park, Jun-Young, et al.
Publicado: (2017)

Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells
por: Kwon, Kyung-Min, et al.
Publicado: (2017)

C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells
por: Brognara, Eleonora, et al.
Publicado: (2011)

Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
por: Kim, Hee-Do, et al.
Publicado: (2023)

The Ganglioside GM3 Is Associated with Cisplatin-Induced Apoptosis in Human Colon Cancer Cells
por: Chung, Tae-Wook, et al.
Publicado: (2014)

6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway
por: Zheng, Li, et al.
Publicado: (2022)

Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity
por: Long, Mark D., et al.
Publicado: (2015)

Induction of Erythroid Differentiation by 5‐Fluorouracil in K562 Leukemia Cells
por: Yang, Ya‐Wun, et al.
Publicado: (1995)

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
por: Prado-Carrillo, Omar, et al.
Publicado: (2022)

Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells
por: Fukushi, Abekura, et al.
Publicado: (2022)

Intestine specific regulation of pig cytidine-5′-monophospho-N-acetylneuraminic acid hydroxylase gene for N-glycolylneuraminic acid biosynthesis
por: Song, Kwon-Ho, et al.
Publicado: (2019)

Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells
Publicado: (1976)

Induction of in vitro proliferation and maturation of human aneuploid myelogenous leukemic cells
Publicado: (1982)

Leukemic retinophaty, the first manifestation in a case of acute myelogenous leukemia
por: Scripcă, Oana Roxana, et al.
Publicado: (2018)

Effects of THAP11 on Erythroid Differentiation and Megakaryocytic Differentiation of K562 Cells
por: Kong, Xiang-Zhen, et al.
Publicado: (2014)

Erythroid blast crisis in chronic myelogenous leukemia: Case report and review of literature
por: Nagamos, Rochelle Nagales, et al.
Publicado: (2016)

Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells
por: Huang, Huey-Lan, et al.
Publicado: (2011)

Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell
por: Niakani, Maryam, et al.
Publicado: (2020)

Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
por: Rai, Yogesh, et al.
Publicado: (2019)

Secretion of Transforming Growth Factor‐ß by Human Myelogenous Leukemic Cells and Its Possible Role in Proliferation of the Leukemic Cells
por: Komatsu, Keiko, et al.
Publicado: (1989)

MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells
por: Yuan, Jin-Yun, et al.
Publicado: (2009)

Transglutaminase 2 regulates terminal erythroid differentiation via cross-linking activity
por: Zhang, Yingying, et al.
Publicado: (2023)

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
por: Shi, Dan, et al.
Publicado: (2016)

Curcumin and Curcumin-Loaded Nanogel Induce Apoptosis Activity in K562 Chronic Myelogenous Leukemia Cells
por: Khatamsaz, Sepideh, et al.
Publicado: (2018)

Avenanthramide C Suppresses Matrix Metalloproteinase-9 Expression and Migration Through the MAPK/NF- κB Signaling Pathway in TNF-α-Activated HASMC Cells
por: Park, Junyoung, et al.
Publicado: (2021)

Unravelling pathways downstream Sox6 induction in K562 erythroid cells by proteomic analysis
por: Barbarani, Gloria, et al.
Publicado: (2017)

Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis
por: WANG, QING, et al.
Publicado: (2015)

Human Platelets Effectively Kill K‐562 Cells, a Chronic Myelogenic Leukemia Cell Line, in vitro
por: Sagawa, Terutaka, et al.
Publicado: (1990)

Focal lymphoblastic transformation of chronic myelogenous leukemia develops into erythroid leukemia: A case report
por: Wang, Wei, et al.
Publicado: (2023)

A Patient with Pure Erythroid Leukemia with Leukemic Cells Mimicking Myeloma Cells
por: Song, Guoliang, et al.
Publicado: (2022)

Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID Mouse In Vivo
por: Shirasaki, Ryosuke, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i795bmaq1ifkd2dkaikh7u5sig